Kimberly-Clark Corporation (KMB) is a Texas-based company producing personal care products, with a market cap of $44.3 billion. Despite recent underperformance in the market, KMB stock rose by 4.8% after reporting Q2 results, beating EPS estimates. Analysts predict a 10.7% decline in EPS for the current fiscal year, with a consensus rating of “Moderate Buy.”

The stock’s performance has lagged behind the S&P 500 Index and the Consumer Staples Select Sector SPDR Fund. However, KMB has a history of beating or matching consensus estimates. Analysts are generally positive on KMB, with a mean price target of $142.89, implying a 6% premium to current levels.

TD Cowen analyst Robert Moskow maintains a “Hold” rating on KMB with a price target of $145, suggesting a potential 7.6% upside. The highest price target of $162 indicates a 20.2% potential increase. This information is for informational purposes only and does not reflect the author’s positions in mentioned securities.

Read more at Yahoo Finance: Kimberly-Clark Stock: Analyst Estimates & Ratings